Bausch & Lomb (BLCO) Non-Current Assets (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Non-Current Assets came in at $10.9 billion in Q2 2026, little changed on a YoY basis from $11.0 billion in Q2 2025, and down 0.61% quarter-over-quarter from $11.0 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Non-Current Assets (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Non-Current Assets for 6 consecutive years, with $10.9 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets changed 0.45% year-over-year to $10.9 billion; the trailing twelve-month figure through Jun 2026 stood at $44.0 billion (up 2.03% YoY), and the FY2025 full-year result was $11.0 billion, up 3.41% from the prior year.
- Non-Current Assets fell to $10.9 billion in Q2 2026 per BLCO's latest filing, from $11.0 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $11.0 billion in Q4 2025 and bottomed at $8.8 billion in Q3 2022.
- Historically, Non-Current Assets has averaged $10.2 billion across 5 years, with a median of $10.6 billion in 2023.
- The widest YoY moves for Non-Current Assets: up 20.0% in 2023, down 2.21% in 2023.
- Over 5 years, Non-Current Assets stood at $9.0 billion in 2022, then gained by 18.8% to $10.7 billion in 2023, then declined by 0.18% to $10.7 billion in 2024, then gained by 3.41% to $11.0 billion in 2025, then fell by 0.98% to $10.9 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $10.9 billion, $11.0 billion, and $11.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 10.94 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.94 Bn |
| Mar 31, 2026 | 11.00 Bn |
| Dec 31, 2025 | 11.05 Bn |
| Sep 30, 2025 | 10.98 Bn |
| Jun 30, 2025 | 10.99 Bn |
| Mar 31, 2025 | 10.73 Bn |
| Dec 31, 2024 | 10.68 Bn |
| Sep 30, 2024 | 10.69 Bn |
| Jun 30, 2024 | 10.48 Bn |
| Mar 31, 2024 | 10.55 Bn |
| Dec 31, 2023 | 10.70 Bn |
| Sep 30, 2023 | 10.60 Bn |
| Jun 30, 2023 | 9.00 Bn |
| Mar 31, 2023 | 8.99 Bn |
| Dec 31, 2022 | 9.01 Bn |
| Sep 30, 2022 | 8.84 Bn |
| Jun 30, 2022 | 9.00 Bn |
| Mar 31, 2022 | 9.19 Bn |
| Dec 31, 2021 | 9.19 Bn |